5Cividalli A, Ceciarelli F, Livid E, et al. Radiosensitization by oxaliplatin in a mouse adenocareinoma: influence of treatment schedule [ J ]. Int-J-Radiat-Oncol-Biol-Phys ,2002, 52 (4) : 1092 - 1098.
6Zeng ZC, Tang ZY, Wu ZQ, et al. Phase Ⅰ clinical trial of oral furtulon and combined hepatic arterial chemoembolization and radiotherapy in unreseetable primary liver cancers, including clinicopathologic study [ J ]. Am-J-Clin-Oncol, 2000, 23 ( 5 ) : 449 - 454.
7Legallieier B,Leclere C, Monteil C, et al. The eellular toxicity of two antitumoral agents derived from platinum, eisplatinum versus oxaliplatinum, on euhares of tubular proximal cells [ J]. Drugs Exp Cliu Res, 1996, 22(2) : 41 -50.
8Sargent JM, Taylor CG. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia [ J]. Br J Cancer, 1989,60 ( 2 ) : 206.
9Rotman M,Aziz H, Wasserman TH,et al. Chemotherapy and irradiation.In: Perez CA, Brady LW, eds. Principles and Practice of Radiation oncology.3rd ed. New York: Lippincott-Raven PRESS, 1997.705-723.
5Eisenhauer E A, Therasse P, Bogaerts J, et al.New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J].Eur J Cancer, 2009, 45(2): 228-247.
6Díaz-Rubio E, Tabernero J, Gómez-Espa?a A, et al.Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial[J].J Clin Oncol, 2007, 25(27): 4224-4230.
7Lin Q, Gao X S, Qiao X Y, et al.Phase Ⅰ trial of escalating dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer[J].Acta Med Okayama, 2009, 62(1): 37-44.
8Schull B, Kornek G V, Schmid K, et al.Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer[J].Oncology, 2011, 65(3): 211-217.
